These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 31111585)

  • 1. Guidelines for the management of Helicobacter pylori infection in Japan: 2016 Revised Edition.
    Kato M; Ota H; Okuda M; Kikuchi S; Satoh K; Shimoyama T; Suzuki H; Handa O; Furuta T; Mabe K; Murakami K; Sugiyama T; Uemura N; Takahashi S
    Helicobacter; 2019 Aug; 24(4):e12597. PubMed ID: 31111585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concomitant therapy achieved the best eradication rate for Helicobacter pylori among various treatment strategies.
    Lee HJ; Kim JI; Lee JS; Jun EJ; Oh JH; Cheung DY; Chung WC; Kim BW; Kim SS
    World J Gastroenterol; 2015 Jan; 21(1):351-9. PubMed ID: 25574111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The updated JSPGHAN guidelines for the management of Helicobacter pylori infection in childhood.
    Kato S; Shimizu T; Toyoda S; Gold BD; Ida S; Ishige T; Fujimura S; Kamiya S; Konno M; Kuwabara K; Ushijima K; Yoshimura N; Nakayama Y;
    Pediatr Int; 2020 Dec; 62(12):1315-1331. PubMed ID: 32657507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guidelines in the management of Helicobacter pylori infection in Japan.
    Asaka M; Satoh K; Sugano K; Sugiyama T; Takahashi S; Fukuda Y; Ota H; Murakami K; Kimura K; Shimoyama T
    Helicobacter; 2001 Sep; 6(3):177-86. PubMed ID: 11683920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of lafutidine and rabeprazole in 7-day second-line amoxicillin- and metronidazole-containing triple therapy for Helicobacter pylori: a pilot study.
    Kudo T; Fujinami H; Ando T; Nishikawa J; Ogawa K; Hosokawa A; Orihara T; Murakami J; Takahara T; Sugiyama T
    Helicobacter; 2012 Aug; 17(4):277-81. PubMed ID: 22759327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of PPI, levofloxacin and amoxicillin in the eradication of Helicobacter pylori compared to conventional triple therapy at a Venezuelan hospital.
    Dib J; Alvarez B; Mendez L; Cruz ME
    Arab J Gastroenterol; 2013 Sep; 14(3):123-5. PubMed ID: 24206741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidelines for the management of Helicobacter pylori infection in Japan: current status and future prospects.
    Fujioka T; Yoshiiwa A; Okimoto T; Kodama M; Murakami K
    J Gastroenterol; 2007 Jan; 42 Suppl 17():3-6. PubMed ID: 17238017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonbismuth quadruple (concomitant) therapy: empirical and tailored efficacy versus standard triple therapy for clarithromycin-susceptible Helicobacter pylori and versus sequential therapy for clarithromycin-resistant strains.
    Molina-Infante J; Pazos-Pacheco C; Vinagre-Rodriguez G; Perez-Gallardo B; Dueñas-Sadornil C; Hernandez-Alonso M; Gonzalez-Garcia G; Mateos-Rodriguez JM; Fernandez-Bermejo M; Gisbert JP
    Helicobacter; 2012 Aug; 17(4):269-76. PubMed ID: 22759326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of tailored Helicobacter pylori eradication treatment based on clarithromycin susceptibility and maintenance of acid secretion.
    Sugimoto M; Uotani T; Sahara S; Ichikawa H; Yamade M; Sugimoto K; Furuta T
    Helicobacter; 2014 Aug; 19(4):312-8. PubMed ID: 24690010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends of second-line eradication therapy for Helicobacter pylori in Japan: a multicenter study in the Tokyo metropolitan area.
    Asaoka D; Nagahara A; Matsuhisa T; Takahashi S; Tokunaga K; Kawai T; Kawakami K; Suzuki H; Suzuki M; Nishizawa T; Kurihara N; Ito M; Sasaki H; Omata F; Mizuno S; Torii A; Ohkusa T; Mine T; Sakaki N
    Helicobacter; 2013 Dec; 18(6):468-72. PubMed ID: 23773231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of Vonoprazan for Helicobacter pylori Eradication.
    Kiyotoki S; Nishikawa J; Sakaida I
    Intern Med; 2020 Jan; 59(2):153-161. PubMed ID: 31243237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guidelines for the management of Helicobacter pylori infection in Japan: 2009 revised edition.
    Asaka M; Kato M; Takahashi S; Fukuda Y; Sugiyama T; Ota H; Uemura N; Murakami K; Satoh K; Sugano K;
    Helicobacter; 2010 Feb; 15(1):1-20. PubMed ID: 20302585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel Potassium-Competitive Acid Blocker Improves the Efficacy of Clarithromycin-containing 7-day Triple Therapy against Helicobacter pylori.
    Noda H; Noguchi S; Yoshimine T; Goji S; Adachi K; Tamura Y; Izawa S; Ebi M; Yamamoto S; Ogasawara N; Funaki Y; Sasaki M; Kasugai K
    J Gastrointestin Liver Dis; 2016 Sep; 25(3):283-8. PubMed ID: 27689190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of three different proton pump inhibitors with amoxicillin and metronidazole in retreatment for Helicobacter pylori infection.
    Murakami K; Okimoto T; Kodama M; Sato R; Watanabe K; Fujioka T
    J Clin Gastroenterol; 2008 Feb; 42(2):139-42. PubMed ID: 18209581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of metronidazole as second-line drug for the treatment of Helicobacter pylori Infection in the Japanese population: a multicenter study in the Tokyo Metropolitan Area.
    Matsuhisa T; Kawai T; Masaoka T; Suzuki H; Ito M; Kawamura Y; Tokunaga K; Suzuki M; Mine T; Takahashi S; Sakaki N
    Helicobacter; 2006 Jun; 11(3):152-8. PubMed ID: 16684262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triple therapy with high-dose proton-pump inhibitor, amoxicillin, and doxycycline is useless for Helicobacter pylori eradication: a proof-of-concept study.
    Almeida N; Romãozinho JM; Donato MM; Luxo C; Cardoso O; Cipriano MA; Marinho C; Sofia C
    Helicobacter; 2014 Apr; 19(2):90-7. PubMed ID: 24506175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of first-line triple therapy with a potassium-competitive acid blocker for Helicobacter pylori eradication in children.
    Kusano C; Gotoda T; Suzuki S; Ikehara H; Moriyama M
    J Gastroenterol; 2018 Jun; 53(6):718-724. PubMed ID: 29110085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Four-times-daily Dosing of Rabeprazole with Sitafloxacin, High-Dose Amoxicillin, or Both for Metronidazole-Resistant Infection with Helicobacter pylori in Japan.
    Sugimoto M; Sahara S; Ichikawa H; Kagami T; Ban H; Otsuka T; Andoh A; Furuta T
    Helicobacter; 2017 Feb; 22(1):. PubMed ID: 27213463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helicobacter pylori eradication therapy.
    Suzuki H; Nishizawa T; Hibi T
    Future Microbiol; 2010 Apr; 5(4):639-48. PubMed ID: 20353303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neither 10- nor 14-Day Sequential Treatment is better than Standard Triple Therapy for Helicobacter Pylori Eradication.
    Warrington E; López-Román O; Tirado Montijo R; Urbina R; Cruz-Correa M; Toro DH
    P R Health Sci J; 2016 Dec; 35(4):203-208. PubMed ID: 27898166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.